Pu X - Search Results

1

Comparison of KRAS/BRAF mutations between primary tumors and serum in colorectal cancer: Biological and clinical implications.

Pu X, Pan Z, Huang Y, Tian Y, Guo H, Wu L, He X, Chen X, Zhang S, Lin T. Pu X, et al. Oncol Lett. 2013 Jan;5(1):249-254. doi: 10.3892/ol.2012.963. Epub 2012 Oct 10. Oncol Lett. 2013. PMID: 23255930 Free PMC article.

2

[Effect of KRAS mutation on efficacy of Cetuximab combined with chemotherapy in advanced colorectal cancer patients].

Pu XX, Deng YH, Xu F, Xiao J, Guo HQ, Huang H, Tian Y, He YJ, Lin TY. Pu XX, et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2009 Nov;12(6):594-7. Zhonghua Wei Chang Wai Ke Za Zhi. 2009. PMID: 19921572 Chinese.

3

The role of Skp2 in extranodal NK/T-cell lymphoma.

Guo HQ, Pu XX, Guo CC, Rao HL, Li HR, Lin TY. Guo HQ, et al. Chin J Cancer. 2010 May;29(5):567-71. doi: 10.5732/cjc.009.10645. Chin J Cancer. 2010. PMID: 20426910 Free article.

4

5-Fluorouracil upregulates the activity of Wnt signaling pathway in CD133-positive colon cancer stem-like cells.

Deng YH, Pu XX, Huang MJ, Xiao J, Zhou JM, Lin TY, Lin EH. Deng YH, et al. Chin J Cancer. 2010 Sep;29(9):810-5. doi: 10.5732/cjc.010.10134. Chin J Cancer. 2010. PMID: 20800023 Free article.

5

Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression.

Pu XX, Huang GL, Guo HQ, Guo CC, Li H, Ye S, Ling S, Jiang L, Tian Y, Lin TY. Pu XX, et al. J Gastroenterol Hepatol. 2010 Oct;25(10):1674-80. doi: 10.1111/j.1440-1746.2010.06417.x. J Gastroenterol Hepatol. 2010. PMID: 20880178

6

Diagnostic and prognostic value of circulating miR-221 for extranodal natural killer/T-cell lymphoma.

Guo HQ, Huang GL, Guo CC, Pu XX, Lin TY. Guo HQ, et al. Dis Markers. 2010;29(5):251-8. doi: 10.3233/DMA-2010-0755. Dis Markers. 2010. PMID: 21206010 Free PMC article.

7

p63 Expression is a prognostic factor in colorectal cancer.

Guo HQ, Huang GL, Liu OF, Liu YY, Yao ZH, Yao SN, Zhao Y, Liu T, Pu XX, Lin TY, Yang SJ. Guo HQ, et al. Int J Biol Markers. 2012 Oct 8;27(3):e212-8. doi: 10.5301/JBM.2012.9581. Int J Biol Markers. 2012. PMID: 23015401 Free article.

8

miR-96 induces cisplatin chemoresistance in non-small cell lung cancer cells by downregulating SAMD9.

Wu L, Pu X, Wang Q, Cao J, Xu F, Xu LI, Li K. Wu L, et al. Among authors: pu x. Oncol Lett. 2016 Feb;11(2):945-952. doi: 10.3892/ol.2015.4000. Epub 2015 Dec 3. Oncol Lett. 2016. PMID: 26893673 Free PMC article.

9

Association of microRNA-423 rs6505162 C>A polymorphism with susceptibility and metastasis of colorectal carcinoma.

Jia W, Zeng L, Luo S, Bai F, Zhong R, Wu L, Huang GL, Pu X. Jia W, et al. Among authors: pu x. Medicine (Baltimore). 2018 Feb;97(6):e9846. doi: 10.1097/MD.0000000000009846. Medicine (Baltimore). 2018. PMID: 29419695 Free PMC article.

10

Dose-Dense Rituximab-CHOP versus Standard Rituximab-CHOP in Newly Diagnosed Chinese Patients with Diffuse Large B-Cell Lymphoma: A Randomized, Multicenter, Open-Label Phase 3 Trial.

Li X, Huang H, Xu B, Guo H, Lin Y, Ye S, Yi J, Li W, Wu X, Wang W, Zhan H, Xie D, Peng J, Cao Y, Pu X, Guo C, Hong H, Wang Z, Fang X, Zhou Y, Lin S, Liu Q, Lin T. Li X, et al. Among authors: pu x. Cancer Res Treat. 2019 Jul;51(3):919-932. doi: 10.4143/crt.2018.230. Epub 2018 Oct 2. Cancer Res Treat. 2019. PMID: 30282447 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,904 results

Search Page

Filters